NPI: 1275771891 · ORLANDO, FL 32804 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/04/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/04/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,593 | $2.82M |
| 2019 | 23,713 | $4.09M |
| 2020 | 26,507 | $5.07M |
| 2021 | 17,872 | $1.58M |
| 2022 | 8,134 | $1.56M |
| 2023 | 8,641 | $478K |
| 2024 | 5,565 | $267K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,389 | 2,484 | $5.03M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,424 | 1,553 | $4.76M |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,026 | 1,373 | $2.65M |
| J1756 | Injection, iron sucrose, 1 mg | 6,031 | 971 | $815K |
| A4657 | Syringe, with or without needle, each | 4,531 | 1,973 | $801K |
| 85041 | 1,820 | 1,267 | $286K | |
| 85048 | 1,808 | 1,261 | $285K | |
| 83970 | 1,611 | 1,071 | $268K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,421 | 270 | $225K |
| 83540 | 1,328 | 977 | $213K | |
| 83550 | 1,259 | 928 | $213K | |
| 82728 | 1,311 | 955 | $205K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 572 | 251 | $52K |
| 82108 | 121 | 94 | $20K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 129 | 96 | $18K |
| G0008 | Administration of influenza virus vaccine | 83 | 61 | $8K |
| 90674 | 38 | 32 | $8K | |
| 0001A | 25 | 12 | $4K | |
| J2501 | Injection, paricalcitol, 1 mcg | 98 | 12 | $0.00 |